Elevating patient health: advanced taste capabilities, CBD-based formulations, and pharma expert services from dsm-firmenich at CPHI 2024

Located at booth 3B25 (API Hall 3), dsm-firmenich will demonstrate its ongoing commitment to advancing the global pharma market and elevating therapy development – with the spotlight on its first-to-market CBtru® drug product intermediate and cutting-edge taste modulation solutions for enhanced therapy convenience and compliance. In addition, dsm-firmenich will highlight how its service program combines Quality, Regulatory and Sustainability expertise to address evolving customer pain points within the pharmaceutical market.

Patient-first approach to innovation

Kicking off the show, dsm-firmenich is excited to present the newest addition to its unique cannabinoid portfolio – CBtru®, a pioneering cannabidiol (CBD) drug product intermediate designed for oral solid dosage forms. By enabling higher drug loading (more of the active ingredient in the formulation), improved stability and optimized pharmacokinetic performance, CBtru® is set to pave the way for more convenient and patient-friendly CBD-based medicines. 

In addition to CBtru®, dsm-firmenich will present how its cutting-edge taste modulation solutions are also helping to elevate medicine acceptance. “Therapies are only effective if adhered to. However, over 60% of APIs in the market are considered bitter. That’s why, among other challenges, we’re tackling API bitterness head-on,” says Fernanda Onofre, Global Market Development Manager, Pharma Excipients. “We have the capabilities to map bitterness receptors and how they interact with APIs, allowing us to develop highly effective and specific bitter blockers. These insights could have a huge impact in galenic forms especially, such as orally disintegrating tables and films and oral liquids, where the formulation components come into direct contact with the tongue.” 

Elevated drug formulation

At booth 3B25, dsm-firmenich will showcase its extensive range of premium specialty ingredients – featuring GMP-compliant vitamins and vitamin derivatives and advanced flavor tonalities and taste modulators. Fernanda Onofre says: “We understand the unique and complex formulation hurdles that drug manufacturers may face – and where the right excipient can make all the difference, particularly when it comes to the taste of medicines. With a strong legacy in taste science and innovation, we are well-positioned to apply our deep knowledge and elevate pharmaceutical formulations and processes to another level.” 

Next level service excellence

Finally, dsm-firmenich enhanced service program, powered by dedicated Quality, Regulatory and Sustainability expertise, helps drug developers navigate and meet the high standards and regulatory requirements of differentiated applications and markets. “The program offers several service levels to meet specific customer needs and provides access to our broad portfolio of high-quality pharmaceutical ingredients supported by comprehensive dossiers and global market access,” comments Kelsey Achenbach, Vice President Pharma at dsm-firmenich. “As one of the only suppliers with EcoVadis Platinum certification, we also help our partners drive innovation with environmental responsibility at its core. This includes providing ingredient-level data and in-house Life Cycle Assessments (LCAs) expertise to help customers achieve their own sustainability targets, including Scope 3 goals. The focus on Sustainability services underlines our existing platform, where we ensure our customers have the highest-level support to serve patients across the globe. Only few suppliers continue to support the continuous changing regulatory landscape and the increasingly strict quality requirements of the pharmaceutical industry. We take pride in being a reliable partner of the supply chain, to help elevate patient health with safe and effective therapies worldwide.” 

For more information about dsm-firmenich’s patient-inspired innovations, formulation solutions and advanced expert service program, visit booth 3B25 (API Hall 3) at CPHI or to book a meeting, click here: https://www.dsm.com/pharma/en/events/cphi.html 

About dsm-firmenich

As innovators in nutrition, health, and beauty, dsm-firmenich reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world’s growing population to thrive. With our comprehensive range of solutions, with natural and renewable ingredients and renowned science and technology capabilities, we work to create what is essential for life, desirable for consumers, and more sustainable for the planet. dsm-firmenich is a Swiss-Dutch company, listed on the Euronext Amsterdam, with operations in almost 60 countries and revenues of more than €12 billion. With a diverse, worldwide team of nearly 30,000 employees, we bring progress to life™ every day, everywhere, for billions of people.